EchoGo

DEVICE2 trials

Sponsors

Ultromics Ltd

Conditions

CancerCardiotoxicityCoronary Heart Disease

Unknown Phase

Mazankowski Alberta Heart Institute (MAHI) EchoGo Discovery 1 Protocol

Ultromics LtdCancer, Cardiotoxicity

Start: 2020-10-08End: 2021-11-30Target: 250Updated: 2021-09-05

PROTEUS: Evaluating the Use of Artificial Intelligence to Support Stress Echocardiography Testing for Heart Disease

Ultromics LtdCoronary Heart Disease

Start: 2021-11-08End: 2023-12-31Updated: 2023-11-30

Related Papers

Experiences of using artificial intelligence in healthcare: a qualitative study of UK clinician and key stakeholder perspectives

BMJ Open2023-12-0128 citations

PROTEUS Study: A Prospective Randomized Controlled Trial Evaluating the Use of Artificial Intelligence in Stress Echocardiography.

2023-05-1412 citations